Foresite Capital Management V LLC Has $11 05 Million Position in Theseus Pharmaceuticals, Inc (NASDAQ:THRX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Chairman at Iovance Biotherapeutics, Inc., Discover Iain Dukes's known position history, network and 100 relationships. Find out about his known public assets.
NEW YORK, Feb. 5, 2024 /PRNewswire/ Monteverde & Associates PC , has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services.
As previously announced on December 22, 2023, Concentra Biosciences, LLC and its wholly owned subsidiary, Concentra Merger Sub II, Inc. , entered into a merger agreement with Theseus.
NEW YORK, Jan. 23, 2024 /PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or.